Cohort expansion from the phase 1 JEWEL-101 study investigating the tissue factor–targeting antibody-drug conjugate XB002 in patients with advanced solid tumors: Metastatic castration-resistant prostate cancer cohort.
| Autor: | Ulahannan, Susanna Varkey, Johnson, Melissa Lynne, Weiss, Mia C., Vandross, Andrae L., Vidal-Cardenas, Sofia Luz, Syed, Mustafa, Tolcher, Anthony W. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS237-TPS237, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|